Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance
Purpose: In recent years, immune checkpoint inhibitors have become a major therapeutic method for the treatment of metastatic colorectal cancer (mCRC). Growing evidence indicates that tumour-infiltrating lymphocytes (TILs) in the tumour microenvironment are a prerequisite for the effectiveness of PD...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2023-02-01
|
| Series: | Heliyon |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844023002554 |
| _version_ | 1811161866718674944 |
|---|---|
| author | Haisong Xin Chaoxi Zhou Guanglin Wang Yan Liu Juan Zhang Youqiang Liu Baokun Li Jianfeng Zhang Mingming Su Zhihan Li Guiying Wang |
| author_facet | Haisong Xin Chaoxi Zhou Guanglin Wang Yan Liu Juan Zhang Youqiang Liu Baokun Li Jianfeng Zhang Mingming Su Zhihan Li Guiying Wang |
| author_sort | Haisong Xin |
| collection | DOAJ |
| description | Purpose: In recent years, immune checkpoint inhibitors have become a major therapeutic method for the treatment of metastatic colorectal cancer (mCRC). Growing evidence indicates that tumour-infiltrating lymphocytes (TILs) in the tumour microenvironment are a prerequisite for the effectiveness of PD-1/PD-L1 blockade therapy. In this study, we aimed to compare PD-L1 expression and cluster of differentiation 4 (CD4) and CD8 TIL infiltration in primary tumours and paired metastases. Patients and methods: Altogether, 111 patients with mCRC who underwent surgery at our hospital were included. PD-L1, CD4, and CD8 expression were detected by immunohistochemistry in a tissue microarray. PD-L1 expression was assessed using the combined positivity score (CPS), and a score ≥1 was judged as positive. The area proportion of TILs with positive staining ≥10% was classified as “high”, while <10% was classified as “low”. Results: We observed the discordance of PD-L1 expression between primary tumours and paired metastases in 35/111 (31.5%) patients (κ = 0.137, P = 0.142). This heterogeneity was significantly correlated with discordance of CD8 TIL infiltration between primary tumours and paired metastases (P = 0.003). Compared with corresponding colorectal cancer tumours, lung metastases showed more CD8 TIL infiltration (P = 0.022, median: 8.5% vs. 5.0%), whereas liver metastases exhibited less CD8 TIL infiltration (P = 0.028, median: 3.0% vs. 5.0%). Area proportion of CD4+ and CD8+ TIL infiltration in lung metastases were all higher than those in liver metastases (P = 0.005, median: 15.0% vs. 9.0%; P = 0.001, median: 8.5% vs. 3.0%). Compared with p MMR (MSI-L/MS-S) subgroup, area proportion of CD8 TIL infiltration in primary tumours and CD4, CD8 TIL infiltration in paired metastases were all higher in d MMR (MSI-H) group (P = 0.026, median: 15.0% vs 5.0%; P = 0.039, median: 15.0% vs 9.0%; P = 0.015, median: 15.0% vs 5.0%). Preoperative chemo/radiotherapy may increase CD8 TIL infiltration in primary tumours (P = 0.045, median: 10.0% vs. 5.0%). CD8 TIL infiltration in primary tumours was an independent predictive factor for overall survival (HR 0.28, 95% CI 0.09–0.93, P = 0.038). Conclusion: Heterogeneity in PD-L1 expression and CD8 TIL infiltration was found between primary tumours and paired metastases in mCRC. CD8 TIL infiltration in primary tumours could independently forecast the overall survival of patients with mCRC. |
| first_indexed | 2024-04-10T06:20:58Z |
| format | Article |
| id | doaj.art-c978227564fb47d8bec77f67a14af54c |
| institution | Directory Open Access Journal |
| issn | 2405-8440 |
| language | English |
| last_indexed | 2024-04-10T06:20:58Z |
| publishDate | 2023-02-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Heliyon |
| spelling | doaj.art-c978227564fb47d8bec77f67a14af54c2023-03-02T04:59:56ZengElsevierHeliyon2405-84402023-02-0192e13048Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significanceHaisong Xin0Chaoxi Zhou1Guanglin Wang2Yan Liu3Juan Zhang4Youqiang Liu5Baokun Li6Jianfeng Zhang7Mingming Su8Zhihan Li9Guiying Wang10Department of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of Endocrinology, Hebei Medical University Third Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of ChinaDepartment of General Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, People’s Republic of China; Department of General Surgery, Hebei Medical University Fourth Affiliated Hospital, Shijiazhuang, Hebei, People’s Republic of China; Corresponding author. Department of General Surgery, The Second Hospital of Hebei Medical University, Shijiazhuang City, Hebei Province, 050051, People’s Republic of China.Purpose: In recent years, immune checkpoint inhibitors have become a major therapeutic method for the treatment of metastatic colorectal cancer (mCRC). Growing evidence indicates that tumour-infiltrating lymphocytes (TILs) in the tumour microenvironment are a prerequisite for the effectiveness of PD-1/PD-L1 blockade therapy. In this study, we aimed to compare PD-L1 expression and cluster of differentiation 4 (CD4) and CD8 TIL infiltration in primary tumours and paired metastases. Patients and methods: Altogether, 111 patients with mCRC who underwent surgery at our hospital were included. PD-L1, CD4, and CD8 expression were detected by immunohistochemistry in a tissue microarray. PD-L1 expression was assessed using the combined positivity score (CPS), and a score ≥1 was judged as positive. The area proportion of TILs with positive staining ≥10% was classified as “high”, while <10% was classified as “low”. Results: We observed the discordance of PD-L1 expression between primary tumours and paired metastases in 35/111 (31.5%) patients (κ = 0.137, P = 0.142). This heterogeneity was significantly correlated with discordance of CD8 TIL infiltration between primary tumours and paired metastases (P = 0.003). Compared with corresponding colorectal cancer tumours, lung metastases showed more CD8 TIL infiltration (P = 0.022, median: 8.5% vs. 5.0%), whereas liver metastases exhibited less CD8 TIL infiltration (P = 0.028, median: 3.0% vs. 5.0%). Area proportion of CD4+ and CD8+ TIL infiltration in lung metastases were all higher than those in liver metastases (P = 0.005, median: 15.0% vs. 9.0%; P = 0.001, median: 8.5% vs. 3.0%). Compared with p MMR (MSI-L/MS-S) subgroup, area proportion of CD8 TIL infiltration in primary tumours and CD4, CD8 TIL infiltration in paired metastases were all higher in d MMR (MSI-H) group (P = 0.026, median: 15.0% vs 5.0%; P = 0.039, median: 15.0% vs 9.0%; P = 0.015, median: 15.0% vs 5.0%). Preoperative chemo/radiotherapy may increase CD8 TIL infiltration in primary tumours (P = 0.045, median: 10.0% vs. 5.0%). CD8 TIL infiltration in primary tumours was an independent predictive factor for overall survival (HR 0.28, 95% CI 0.09–0.93, P = 0.038). Conclusion: Heterogeneity in PD-L1 expression and CD8 TIL infiltration was found between primary tumours and paired metastases in mCRC. CD8 TIL infiltration in primary tumours could independently forecast the overall survival of patients with mCRC.http://www.sciencedirect.com/science/article/pii/S2405844023002554Metastatic colorectal cancer (mCRC)Programmed death-ligand 1 (PD-L1)CD8 tumour infiltrating lymphocytes (TILs)HeterogeneityPrognosis |
| spellingShingle | Haisong Xin Chaoxi Zhou Guanglin Wang Yan Liu Juan Zhang Youqiang Liu Baokun Li Jianfeng Zhang Mingming Su Zhihan Li Guiying Wang Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance Heliyon Metastatic colorectal cancer (mCRC) Programmed death-ligand 1 (PD-L1) CD8 tumour infiltrating lymphocytes (TILs) Heterogeneity Prognosis |
| title | Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance |
| title_full | Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance |
| title_fullStr | Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance |
| title_full_unstemmed | Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance |
| title_short | Heterogeneity of PD-L1 expression and CD8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance |
| title_sort | heterogeneity of pd l1 expression and cd8 lymphocyte infiltration in metastatic colorectal cancer and their prognostic significance |
| topic | Metastatic colorectal cancer (mCRC) Programmed death-ligand 1 (PD-L1) CD8 tumour infiltrating lymphocytes (TILs) Heterogeneity Prognosis |
| url | http://www.sciencedirect.com/science/article/pii/S2405844023002554 |
| work_keys_str_mv | AT haisongxin heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT chaoxizhou heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT guanglinwang heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT yanliu heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT juanzhang heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT youqiangliu heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT baokunli heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT jianfengzhang heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT mingmingsu heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT zhihanli heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance AT guiyingwang heterogeneityofpdl1expressionandcd8lymphocyteinfiltrationinmetastaticcolorectalcancerandtheirprognosticsignificance |